Pharmaceutical

Hoth Therapeutics Taps Lantern Pharma’s PredictBBB.ai Platform — Breakthrough AI With 94% Accuracy Driving Next-Gen Drug Development

NEW YORK, Sept. 4, 2025 /PRNewswire/ -- Hoth Therapeutics, Inc. (NASDAQ: HOTH), a clinical-stage biopharmaceutical innovator, today announced that it…

4 months ago

Waterdrop Inc. Announces Second Quarter 2025 Unaudited Financial Results and a Cash Dividend

BEIJING, Sept. 4, 2025 /PRNewswire/ -- Waterdrop Inc. ("Waterdrop", the "Company" or "we") (NYSE: WDH), a leading technology platform dedicated…

4 months ago

DistillerSR Unveils Ready-to-Deploy EU-MDR Literature Review Workflows to Accelerate Notified Body Submissions

OTTAWA, ON / ACCESS Newswire / September 4, 2025 / DistillerSR, the market leader in AI-enabled literature review automation and…

4 months ago

Medical Care Technologies Inc. (OTC PINK:MDCE) Advances Skin Cancer Prevention with AI Mole Tracking System

MESA, ARIZONA / ACCESS Newswire / September 4, 2025 / Medical Care Technologies Inc. (OTC PINK: MDCE) is proud to…

4 months ago

GenHealth Creates 50M Public Patient Dataset

50 Million Medicare Patients. 10 Years. Unlimited Insights. VIENNA, VIRGINIA / ACCESS Newswire / September 4, 2025 / Today, we…

4 months ago

Finetech Launches New Technology for NJP-1200 Capsule Filling Equipment, Achieve Soft Capsule+Granule Into One Hard Capsule

Finetech, a top manufacturer of pharmaceutical machinery, announces its new technology for the NJP 1200 capsule filling machine. This machine…

4 months ago

Interactive Strength Inc. (Nasdaq:TRNR) Investment Drives Sportstech’s Accelerating Growth, with 45% Revenue Growth in August

Current FX rates indicate that the LTM August 2025 Revenue would be approximately $58M with $6M in EBITDASportstech announced May…

4 months ago

Affordable Access to Advanced EBOO IV Therapy: The Longevity Center FL Lowers the Barrier to Integrative Wellness

With the launch of the EBOOST system, Dr. Benjamin Kosubevsky and The Longevity Center FL expand access to cutting-edge regenerative…

4 months ago

Aptevo Unveils Two Next-Generation, Industry Leading Trispecifics, Expanding CD3 Oncology Pipeline to Five Molecules

New candidates, APVO452 and APVO451, harness proprietary ADAPTIR-FLEXTM design to target prostate and multiple solid tumor cancers by simultaneously engaging…

4 months ago

Tenon(R) Medical Announces Second Peer-Reviewed Catamaran Mainsail(TM) Study Publication, Underscores Robust and Sustainable Clinical Outcomes Out to 12 Months

~ Clinically Significant Patient Outcomes Demonstrate Improvements in Pain (VAS) and Disability (ODI), Along with High Patient Satisfaction and Safety…

4 months ago